4//SEC Filing
Rothfuss Cristin 4
Accession 0000950170-25-036693
CIK 0000873303other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 8:00 PM ET
Size
6.4 KB
Accession
0000950170-25-036693
Insider Transaction Report
Form 4
Rothfuss Cristin
EVP, General Counsel
Transactions
- Tax Payment
Common Stock
2025-03-07$103.70/sh−347$35,984→ 11,847 total - Tax Payment
Common Stock
2025-03-07$103.70/sh−1,131$117,285→ 12,194 total
Footnotes (2)
- [F1]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023.
- [F2]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0002046214
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 8:00 PM ET
- Size
- 6.4 KB